Bainan Biotech ApS is a preclinical life science company developing a therapeutic to treat osteoporosis. The company’s GIPR/GLP-2R dual agonist is a first-in-class therapy that leverages on the effects of intestinal hormones to strengthen bones.
If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact email@example.com or +45 5150 0560
Copyright 2020 Danskbiotek. All rights reserved.
created by: Mastafu Design